UF is collaborating on clinical trial testing if high-intensity treadmill exercise is effective in decreasing signs of Parkinson’s.

New study lends insights into factors that could help predict the efficacy of gene therapies using a genetically engineered antibody to target abnormal tau proteins.

CTRND researchers publish new paper in Journal of Neuroscience.

Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.

In new podcast, Dr. Malú Tansey discusses how her team helped lead the way in UF's efforts to bring researchers safely back to the lab.

Article in The Scientist featuring Dr. Malú Tansey examines COVID-19's impact on recruiting.

Dr. Malú Tansey shared research findings on gut-brain communication via the immune system.

Three renowned neuroscientists from top U.S. research institutions — Drs. Malú G. Tansey, Ph.D., Matthew LaVoie, Ph.D., and Stefan Prokop, M.D. — will join the newly established Norman Fixel Institute for Neurological Diseases at UF Health.

Over the last few years, there has been great interest in learning more about the proteins that accumulate in brains affected by various neurodegenerative disorders and the idea that these proteins can spread from one area of the brain to the other. Now, a team of University of Florida neuroscientists…

Chronic neurological diseases — Alzheimer’s disease, Parkinson’s disease, dystonia, ALS (Lou Gehrig’s disease), Huntington’s disease, neuromuscular disease, multiple sclerosis and epilepsy, to mention only a few — afflict millions of Americans worldwide and account for tremendous morbidity and mortality. Furthermore, age is the largest risk factor for many…